OUR MISSION

To improve the quality of human life by enthusiastically enhancing the health, appearance, and comfort of the skin.

OUR VISION
To be the world's most valued and respected dermatology company.

GSK AT A GLANCE

We are a science-led global healthcare company Our mission is to improve the quality of human life by enabling people to do more, feel better and live longer We are committed to tackling the three "priority" diseases identified by the World Health Organization: HIV/AIDS, tuberculosis and malaria In the developing world, we provide certain medicines at preferential prices ensuring that the poorest can still benefit from our treatments and vaccines Our business employs over 97,000 people in over 100 countries Around 12,500 people work in our research teams in the UK, USA, Spain, Belgium and China to discover new medicines We invested nearly 600 million in vaccines R&D in 2011 and we have more than 1,600 scientists working on the development of new vaccines

In 2011, we distributed 1.1 billion doses of vaccines to 173 countries, of which over 80% were supplied to developing countries Our long term vision is for our entire value chain to be carbon neutral by 2050 In November 2009, we launched ViiV Healthcare, a global specialist HIV company established by GlaxoSmithKline and Pfizer to deliver advances in treatment and care for people living with HIV In July 2009 we acquired Stiefel Laboratories, the worlds largest independent dermatology company January 2008 marked the tenth anniversary of our programme to help eliminate lymphatic filariasis (elephantiasis). Since the start of this programme we have donated more than 2 billion albendazole tablets to countries affected by LF In 2007 we marked 15 years of the Positive Action programme that helps communities living with HIV/AIDS. Positive Action is today a programme supported by ViiV Healthcare Many of our consumer brands are household names: Ribena, Horlicks,

HISTORY VIEW IN DIFFEREN DECADES

1715
Plough Court pharmacy, the forerunner of Allen & Hanburys Ltd, is established in London by Silvanus Bevan. Glaxo acquires Allen & Hanburys in 1958.

1830 JOHN K SMITH PHILADELPHIA 1842 1865

AS

OPENS HIS FIRST DRUGSTORE IN

THOMAS BEECHAM BUSINESS IN ENGLAND.

LAUNCHES THE

BEECHAM PILLS

1865 MAHLON KLINE JOINS SMITH & SHOEMAKER JOHN K SMITH & CO HAD BECOME. LATER THE COMPANY

MAHLON K SMITH & COMPANY, WHICH RENAMED SMITH, KLINE & COMPANY IN 1875.
BECOMES

IS

1873 :

1873 JOSEPH NATHAN ESTABLISHES JOSEPH NATHAN AND COMPANY, THE FOUNDATION FOR THE GLAXO COMPANY TO BE FORMED LATER.
IN

1881: BURROUGHS WELLCOME & COMPANY IS ESTABLISHED LONDON BY AMERICAN PHARMACISTS HENRY WELLCOME AND SILAS BURROUGHS. 1989 : SMITHKLINE AND BEECHAM SMITHKLINE BEECHAM. 1995:L GLAXO AND WELLCOME WELLCOME.
MERGE TO FORM

MERGE TO FORM

GLAXO
OF

2000: GLAXOSMITHKLINE IS FORMED BY THE MERGER GLAXO WELLCOME AND SMITHKLINE BEECHAM.

GSK PAKISTAN HISTORY OVERVIEW GlaxoSmithKline Pakistan Limited, the largest pharmaceutical company in Pakistan was incorporated in 2002. GSK Pakistan was formed with the merger of Smith Kline & French Pakistan Limited and Beecham Pakistan (Pvt.) Limited with Glaxo Wellcome Pakistan Limited. Primarily, the company operates in two industry segments: pharmaceuticals (prescription drugs & vaccines) and consumer healthcare (over-the-counter- medicines, oral care & nutritional care). The company manufactures and markets ethical based specialities, other pharmaceutical, animal health and consumer products. GSK Pakistan is the subsidiary of Setfirst Limited UK with 79% stake, whereas its ultimate parent company is GlaxoSmithKline plc, UK.

MARKET NVIEW OF GSK PAKISTAN MAIN COMPETITORS

PRODUCTS
Product portfolio In Pakistan, the product portfolio of GSK ranges from pharmaceuticals, vaccines, over-the-counter (OTC) medicines and health-related consumer products. The pharmaceuticals range covers antibiotics, antidepressant, gastrointestinal, dermatological, respiratory, cancer and cardiovascular medications. The vaccine includes the treatment of diseases like hepatitis A and B, diphtheria, tetanus and influenza. The companys top brands include Amoxil, Ampiclox, Augmentin, Betnovate, Calpol, Panadol, Septran, Seretide, Ventolin and Zantac. Further, during 2007 the company made following additions to its pharmaceutical range. The new launch includes Aerolin Evohaler, Avodart and Rotarix Vaccine.GlaxoSmithKlines pharmaceuticals include the antidepressant Paxil/Seroxat the HIV/AIDS treatment Combivir, Zofran, a treatment for alcoholism, and Avendia a treatment for Type 2 diabetes. Their Consumer Health Products [see Corporate Crimes, Animal Welfare] include Aquafresh Toothpaste, Tums antacid, Nicorette and the nutritonal drinks Horlicks, Lucozade and Ribena.

MANAGED

MARKETS DIVISION

This diverse team is responsible for developing and communicating strategies for all industry customers that might influence the flow of prescription medicines from the manufacturer to the patient. These customers include large purchasers or large reimbursers for prescription medicines, such as wholesalers, hospitals, pharmacies, national and regional HMOs, pharmacy benefit managers (PBMs), insurers and employers, plus state and federal governments.

SUPPORT

FUNCTIONS

Providing an essential range of services behind the scenes, these teams deliver leading edge tools, strategic analysis, and operational support:

GSK response center Ethics and compliance Finance Information Technology (IT) Legal Human resources